Literature DB >> 9416666

The 'amyloid cascade hypothesis' of AD: decoy or real McCoy?

J N Davis, J C Chisholm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9416666     DOI： 10.1016/s0166-2236(97)85989-9

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN： 0166-2236            Impact factor:   13.837


× No keyword cloud information.
  8 in total

1.  Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice.

Authors:  L Mucke; G Q Yu; L McConlogue; E M Rockenstein; C R Abraham; E Masliah
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results From the National Institute of Mental Health's BIOCARD study.

Authors:  P M Greenwood; Chantal Lambert; Trey Sunderland; Raja Parasuraman
Journal:  Neuropsychology       Date:  2005-03       Impact factor: 3.295

3.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

4.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.

Authors:  A Y Hsia; E Masliah; L McConlogue; G Q Yu; G Tatsuno; K Hu; D Kholodenko; R C Malenka; R A Nicoll; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids.

Authors:  B W Howell; L M Lanier; R Frank; F B Gertler; J A Cooper
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

6.  The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.

Authors:  F Peña; Ai Gutiérrez-Lerma; R Quiroz-Baez; C Arias
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

Review 7.  Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder?

Authors:  Rory J Kelleher; Roy L Soiza
Journal:  Am J Cardiovasc Dis       Date:  2013-11-01

8.  Beta-amyloid immunotherapy prevents synaptic degeneration in a mouse model of Alzheimer's disease.

Authors:  Manuel Buttini; Eliezer Masliah; Robin Barbour; Henry Grajeda; Ruth Motter; Kelly Johnson-Wood; Karen Khan; Peter Seubert; Stephen Freedman; Dale Schenk; Dora Games
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.